NIPPV and High-level Pulmonary Support in Neonates
Neonatal pulmonary disorders may require additional respiratory support beyond supplemental oxygen, such as nasal CPAP, HFNC, nasal BiPAP, NIPPV, nHFOV, or even NIV-NAVA.
Neonatal pulmonary disorders may require additional respiratory support beyond supplemental oxygen, such as nasal CPAP, HFNC, nasal BiPAP, NIPPV, nHFOV, or even NIV-NAVA.
Draeger Medical is recalling the Seattle PAP Plus as well as VentStar and other breathing circuit/anesthesia kits after finding that glued connections may loosen before or during ventilation due to a manufacturing error.
Babies born to mothers who vape during pregnancy are at greater risk of developing pulmonary dysfunction, according to a murine study.
The FDA authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 for in children as young as 6 months old.
Read MoreThe FDA’s Vaccine and Related Biological Products Advisory Committee voted unanimously in favor of authorizing the Moderna and Pfizer/BioNTech COVID-19 vaccines for children as young as 6-months old.
Read MoreHydrocortisone is no more effective than placebo at preventing bronchopulmonary dysplasia in infants born before the 30th week of pregnancy, according to NEJM published research.
Read MoreThe US FDA expanded the approval of remdesivir (Veklury, Gilead Sciences) to include pediatric patients 28 days of age and older weighing at least 3 kg with positive results of direct SARS-CoV-2 viral testing.
Read MoreBy analyzing lung tissue samples from newborn and young humans and mice, the researchers were able to gain insights on how certain cell types in the lung originate and change during childhood.
Read MoreChildren younger than age 5 who are infected with the COVID-19 Omicron variant have less risk of severe health outcomes than those infected with the Delta variant, according to research published in JAMA Pediatrics.
Read MoreRaising tobacco taxes is associated with a reduction in neonatal and infant mortality, according to an analysis of data from 159 countries published in Plos Global Public Health.
Read MoreAn investigational RSV vaccine administered to pregnant women reduced RSV-associated lower respiratory tract infections and subsequent antibiotic prescriptions among their infants.
Read MoreAmong infants hospitalized with respiratory syncytial virus (RSV), there was no difference in the amount of wheezing in babies treated with azithromycin versus those who received a placebo.
Read MoreThe investigational long-acting monoclonal antibody Nirsevimab showed 74.5% efficacy against medically attended lower respiratory tract infections caused by RSV in healthy infants.
Read MoreNeonatal patients on ECMO who also had cardiovascular or gastrointestinal conditions were at greater risk for readmission within the first year of their initial discharge.
Read MoreAlarm fatigue is a major patient safety issue in hospital ICUs but how does the problem differ in neonatal and pediatric intensive care units?
Read More